Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Mo

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Computer Methods and Programs in Biomedicine|July 2, 2013
Solving delay differential equations in S-ADAPT by method of stepsRobert J Bauer, Gary Mo, Wojciech Krzyzanski
Plos One|October 22, 2014
Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeuticsGary Mo, Frank Gibbons, Patricia Schroeder, et al.
Molecular Pharmacology|December 20, 2012
Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neuronsGary Mo, Jennifer C Peleshok, Chang-Qing Cao, et al.
Molecular Pain|February 15, 2011
Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase CGary Mo, Rebecca Grant, Dajan O'Donnell, et al.
Clinical and Translational Science|October 17, 2025
Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With MigraineCraig M Comisar, Jim H Hughes, Gary Mo, et al.
Clinical Pharmacokinetics|June 17, 2017
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic CancerGary Mo, John R Baldwin, Debra Luffer-Atlas, et al.
Clinical and Translational Science|April 10, 2025
Large Language Models and Their Applications in Drug Discovery and Development: A PrimerJames Lu, Keunwoo Choi, Maksim Eremeev, et al.
Molecular Pain|August 13, 2009
Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptorsGary Mo, Louis-Philippe Bernier, Qi Zhao, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2018
Systematic Modeling and Design Evaluation of Unperturbed Tumor Dynamics in XenograftsZinnia P Parra-Guillen, Victor Mangas-Sanjuan, Maria Garcia-Cremades, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Computer Methods and Programs in Biomedicine|July 2, 2013
Solving delay differential equations in S-ADAPT by method of stepsRobert J Bauer, Gary Mo, Wojciech Krzyzanski
Plos One|October 22, 2014
Lifespan based pharmacokinetic-pharmacodynamic model of tumor growth inhibition by anticancer therapeuticsGary Mo, Frank Gibbons, Patricia Schroeder, et al.
Molecular Pharmacology|December 20, 2012
Control of P2X3 channel function by metabotropic P2Y2 utp receptors in primary sensory neuronsGary Mo, Jennifer C Peleshok, Chang-Qing Cao, et al.
Molecular Pain|February 15, 2011
Neuropathic Nav1.3-mediated sensitization to P2X activation is regulated by protein kinase CGary Mo, Rebecca Grant, Dajan O'Donnell, et al.
Clinical and Translational Science|October 17, 2025
Exposure Matching Using Population Pharmacokinetic Modeling and Simulation to Support Rimegepant Dose Selection for Pediatric Patients With MigraineCraig M Comisar, Jim H Hughes, Gary Mo, et al.
Clinical Pharmacokinetics|June 17, 2017
Population Pharmacokinetic Modeling of Olaratumab, an Anti-PDGFRα Human Monoclonal Antibody, in Patients with Advanced and/or Metastatic CancerGary Mo, John R Baldwin, Debra Luffer-Atlas, et al.
Clinical and Translational Science|April 10, 2025
Large Language Models and Their Applications in Drug Discovery and Development: A PrimerJames Lu, Keunwoo Choi, Maksim Eremeev, et al.
Molecular Pain|August 13, 2009
Subtype-specific regulation of P2X3 and P2X2/3 receptors by phosphoinositides in peripheral nociceptorsGary Mo, Louis-Philippe Bernier, Qi Zhao, et al.
Cancer Chemotherapy and Pharmacology|November 9, 2018
Exposure-response relationship of olaratumab for survival outcomes and safety when combined with doxorubicin in patients with soft tissue sarcomaRobin L Jones, Gary Mo, John R Baldwin, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 26, 2018
Systematic Modeling and Design Evaluation of Unperturbed Tumor Dynamics in XenograftsZinnia P Parra-Guillen, Victor Mangas-Sanjuan, Maria Garcia-Cremades, et al.
Pageof 2